Helicobacter pylori increases the risk of upper gastrointestinal bleeding in patients taking low-dose aspirin - Wikidata - awgldk - TriplyDB

Helicobacter pylori increases the risk of upper gastrointestinal bleeding in patients taking low-dose aspirin

Helicobacter pylori increases the risk of upper gastrointestinal bleeding in patients taking low-dose aspirin

http://www.wikidata.org/entity/Q28192693

about

sameAs

Clopidogrel and proton pump inhibitors--where do we stand in 2012?Gastrointestinal ulcers, role of aspirin, and clinical outcomes: pathobiology, diagnosis, and treatment Geographic differences in low-dose aspirin-associated gastroduodenal mucosal injury Role of Helicobacter pylori eradication in aspirin or non-steroidal anti-inflammatory drug users Upper gastrointestinal haemorrhage complicating antiplatelet treatment with aspirin and/or clopidogrel: where we are now?Risk of upper gastrointestinal bleeding in patients taking low-dose aspirin for the prevention of cardiovascular diseases Peptic ulcer disease today Treatment and prevention of aspirin-induced gastroduodenal ulcers and gastrointestinal bleeding Prevention of anti-inflammatory drug-induced gastrointestinal damage: benefits and risks of therapeutic strategies My health: whose responsibility? Low-dose aspirin and older people Incidence and predictors of upper gastrointestinal bleeding in patients receiving low-dose aspirin for secondary prevention of cardiovascular events in patients with coronary artery disease Efficacy of Albis for the Prevention of Gastric Mucosal Injury Concomitant with the Use of Low-Dose Aspirin: A Prospective, Randomized, Placebo-Controlled Study.Risk factor profiles, drug usage, and prevalence of aspirin-associated gastroduodenal injuries among high-risk cardiovascular Japanese patients: the results from the MAGIC study Gender differences of low-dose aspirin-associated gastroduodenal ulcer in Japanese patients.Interaction between Helicobacter pylori infection, nonsteroidal anti-inflammatory drugs and/or low-dose aspirin use: old question new insights Risk factors for early and delayed post-operative bleeding after endoscopic submucosal dissection of gastric neoplasms, including patients with continued use of antithrombotic agents Risk management of risk management: Combining proton pump inhibitors with low-dose aspirin Low-dose aspirin-associated upper gastric and duodenal ulcers in Japanese patients with no previous history of peptic ulcers.PPI versus Histamine H2 Receptor Antagonists for Prevention of Upper Gastrointestinal Injury Associated with Low-Dose Aspirin: Systematic Review and Meta-analysis Helicobacter pylori public health implications.Management issues in dyspepsia: current consensus and controversies.The Helicobacter Eradication Aspirin Trial (HEAT): A Large Simple Randomised Controlled Trial Using Novel Methodology in Primary Care.Study of Clinical and Genetic Risk Factors for Aspirin-induced Gastric Mucosal Injury Ageing and the gut Improving the gastrointestinal tolerability of aspirin in older people.Comorbidities affect risk of nonvariceal upper gastrointestinal bleeding.Clinical Risk Factors for Gastroduodenal Ulcer in Romanian Low-Dose Aspirin Consumers Managing peptic ulcer and gastroesophageal reflux disease in elderly Chinese patients--focus on esomeprazole Gastrointestinal bleeding after percutaneous coronary intervention.Systematic review of the epidemiology of complicated peptic ulcer disease: incidence, recurrence, risk factors and mortality.Gastrointestinal effects of aspirin.Aspirin for the older person: report of a meeting at the Royal Society of Medicine, London, 3rd November 2011.Therapeutic management of recurrent peptic ulcer disease.Rabeprazole for the treatment of acid-related disorders.Incidence and risk factors of gastrointestinal bleeding in patients on low-dose aspirin therapy after percutaneous coronary intervention in Japan.3rd Brazilian Consensus on Helicobacter pylori.Aspirin for cardioprotection and strategies to improve patient adherence.Guidelines for the diagnosis and treatment of Helicobacter pylori infection in Korea, 2013 revised edition.Management of low-dose aspirin and clopidogrel in clinical practice: a gastrointestinal perspective.Multinational, double-blind, randomised, placebo-controlled, prospective study of esomeprazole in the prevention of recurrent peptic ulcer in low-dose acetylsalicylic acid users: the LAVENDER study.

P2860

Q26825728-5F632CB7-608A-4015-B1FF-F5A4FA6FEA46 Q27027977-2C578DB9-6632-41F8-9A3F-3226075167A3 Q28085329-A2F9DF3D-051F-48F5-8F77-3C78DDF1DDB3 Q28182449-03272C80-1737-4800-9A6D-CA15DD7E37C1 Q28193564-10937B5F-EB9E-42CA-B003-7F54E936886C Q28193996-12719F9E-015D-4622-AEF8-F01ECF8EEDB4 Q28194844-ED8725E5-A834-4CFB-B559-A8EC673DD0E8 Q28198718-16C00551-EC64-464C-A3A5-2ABC64A8842A Q28200569-2910A0D3-295B-455D-924E-39377D74011F Q28201631-A2EC18D7-0379-4201-8111-AB777DEA7184 Q28218326-103EF014-39AB-470F-9BA0-88EE561399BD Q33583991-2C42972D-9CC5-4383-A666-8D25CFE40755 Q33605890-CA820002-C900-4DF3-A253-FC37E7D216A8 Q33798895-895EAA20-DAA8-4334-AD6C-279D9F14D116 Q34663572-D371F229-D5E5-4137-90C5-7F50989F6878 Q34873381-43717ECA-A505-4A30-A63A-643647227C33 Q35026472-A4D42DBA-ED66-4D2C-AF1B-E71CF7852B5E Q35038558-3076DB2C-1371-49E3-9B14-D2FAA1344E82 Q35683846-34B017D0-8E77-4F2B-A10E-725CB645994E Q35878351-120C5ED1-85F7-45D1-98B3-12CD5A238040 Q35932402-8FF538C2-B40A-46F3-B370-8F6117A10F69 Q36106290-B63EA0F7-62AF-40FE-96A7-4C35A6A52D70 Q36705464-8FFFC3E7-7B5A-46E1-A9B7-6260D4804D97 Q36724430-6A6B6548-361A-4C83-83A3-A9007E621A27 Q37019062-30A4F927-96F4-4D6E-A1A0-21F11E531513 Q37182009-3DEEBD1B-5D95-4A41-9E04-13306000F7C0 Q37192996-08A85EB5-836B-4B5E-B066-565D923FE7C9 Q37260543-268A264D-00D6-4F26-B0C3-B82AE7C8DCA8 Q37832368-DF343E08-637C-495D-B78D-0AFF496F7928 Q37865322-2959F3C2-3398-4C7E-9884-07C8B19C6043 Q37885723-FDE0A6E7-7E8E-4E47-A6C4-445C72E48C2A Q37994187-01C3EDAD-AA6E-4F2E-A660-58FB6DD4242B Q38032319-2666181C-7A16-4054-986F-B6B1A2857FEC Q38038691-8FD76BF8-FCAC-49B6-995B-CE6D33892FD2 Q38072495-A40FDB5E-558B-453B-93EA-E3BEAFB5E741 Q38113105-61EDAF1C-4A81-4D24-8BC9-90EFBF12AD49 Q38176141-310769A6-6D80-4027-AC02-4704DA1BEE7B Q38206548-D27CED61-3BC4-432C-8378-D8E7ED765CA9 Q38321114-E2DBC2AD-44DF-4E92-AE02-07427E6B91FD Q38439626-C6CFE6D0-1E0C-41DE-AC83-BEF2B443934C

P2860

Helicobacter pylori increases the risk of upper gastrointestinal bleeding in patients taking low-dose aspirin

http://www.wikidata.org/entity/Q28192693

description

2002 nî lūn-bûn

@nan

2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Helicobacter pylori increases ...... tients taking low-dose aspirin

@ast

Helicobacter pylori increases ...... tients taking low-dose aspirin

@en

Helicobacter pylori increases ...... tients taking low-dose aspirin

@nl

type

label

Helicobacter pylori increases ...... tients taking low-dose aspirin

@ast

Helicobacter pylori increases ...... tients taking low-dose aspirin

@en

Helicobacter pylori increases ...... tients taking low-dose aspirin

@nl

prefLabel

Helicobacter pylori increases ...... tients taking low-dose aspirin

@ast

Helicobacter pylori increases ...... tients taking low-dose aspirin

@en

Helicobacter pylori increases ...... tients taking low-dose aspirin

@nl

P1433

Q28192693-47E7BFAA-0A97-42F7-ADCA-711159DC9E12

P1476

Q28192693-1E43921F-8C54-4C0B-AABB-4111FD81DC2A

P2093

Q28192693-6CED4213-13EC-4516-8389-142D690287A5

Q28192693-844079D4-D329-47DF-9B9B-6E4A8CBC10B0

Q28192693-8883EE13-0BC8-4D6C-BC06-452B979500E9

Q28192693-8FA3D609-2E3D-498C-ACB7-C703D845E437

Q28192693-96D1BDA0-C9DD-4E20-B9B2-F63BD10E3A75

Q28192693-F9ACA314-E719-4C5F-AF1D-8B7D7AEF2293

P2860

Q28192693-05F8A272-D4DA-4F05-8C81-91A4D605304C

Q28192693-43EE8426-57B6-4C63-9482-A27CDE728F34

Q28192693-4652F70D-C795-4B01-843C-6BED7EBAB7EC

Q28192693-6F8AF0FB-DE23-4CF5-AD56-BD89FE672930

Q28192693-7A476A6A-C49D-40EE-9DDF-615A482815B8

Q28192693-83F40791-193B-4C69-889D-B3696B96BF9A

Q28192693-91DBB084-47EF-4368-A252-87B4E019EE3A

Q28192693-A5720E36-EDA5-4C1E-A4D7-CCC0EC85B001

Q28192693-D7C32952-C8A1-4C08-B6F0-5FE6317DC5D5

Q28192693-DEADE8E4-C90E-4CC5-BE8B-29CE412DF9EA

P304

Q28192693-7BDD4608-42DB-46BE-8E4D-5B2710BBF87D

P31

Q28192693-E9659A76-49F1-463C-8C55-4D83865AE973

P3181

Q28192693-5E14B867-990D-4DD5-A8EA-85934B1FED57

P356

Q28192693-997D19E4-1682-4C11-9B55-94963A0B0297

P407

Q28192693-792C88B8-10D1-44FB-ABB8-2F47D3CD8671

P433

Q28192693-876189CB-93AD-481D-BC8B-D322866DBCB4

P478

Q28192693-A5273F34-BCCC-48AC-8DF6-C9C135EF3E0A

P577

Q28192693-F7210FA1-C25E-4897-B403-5F4FA73F6A2A

P5875

Q28192693-400B2163-1B1B-4DC5-B8C1-D1C101B6A0CC

P698

Q28192693-C7EAE5FB-D67F-4B1D-B142-4A03A43AA28B

P921

Q28192693-5D86EA92-D7BE-411B-A45D-92B1CF458593

Q28192693-C1BA7BEE-73B4-4A7E-BA77-659625033AAD

Q28192693-D5C35F88-9016-4AF3-A2F0-05E9A00F4606

P3181

P356

J.1365-2036.2002.01230.X

P1433

Alimentary Pharmacology & Therapeutics

P1476

Helicobacter pylori increases ...... tients taking low-dose aspirin

@en

P2093

A Lanas

http://www.w3.org/2001/XMLSchema#string

E Bajador

http://www.w3.org/2001/XMLSchema#string

J Fuentes

http://www.w3.org/2001/XMLSchema#string

P Serrano

http://www.w3.org/2001/XMLSchema#string

R Benito

http://www.w3.org/2001/XMLSchema#string

R Sáinz

http://www.w3.org/2001/XMLSchema#string

P2860

Peptic ulcer bleeding in the elderly: relative roles of Helicobacter pylori and non-steroidal anti-inflammatory drugs

Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen

Recent developments in the epidemiology of Helicobacter pylori.

Role of Helicobacter pylori in ulcer healing and recurrence of gastric and duodenal ulcers in longterm NSAID users. Response to omeprazole dual therapy

Risks of gastrointestinal bleeding during secondary prevention of vascular events with aspirin--analysis of gastrointestinal bleeding during the UK-TIA trial.

Prophylactic aspirin and risk of peptic ulcer bleeding.

Risk of ulcer bleeding in patients infected with Helicobacter pylori taking non-steroidal anti-inflammatory drugs.

Experimental esophagitis induced by acid and pepsin in rabbits mimicking human reflux esophagitis.

Nonsteroidal anti-inflammatory drug-associated upper gastrointestinal lesions in rheumatoid arthritis patients. Relationships to gastric histology, Helicobacter pylori infection, and other risk factors for peptic ulcer.

Helicobacter pylori and risk of ulcer bleeding among users of nonsteroidal anti-inflammatory drugs: A case-control study☆, ☆☆

P304

779-86

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4197244

http://www.w3.org/2001/XMLSchema#string

P356

10.1046/J.1365-2036.2002.01230.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2002-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11436871

http://www.w3.org/2001/XMLSchema#string

P698

11929396

http://www.w3.org/2001/XMLSchema#string

P921

Helicobacter pylori